Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Non-Board Appointments

9 May 2005 07:01

Premier Research Group09 May 2005 For Immediate Release 9 May 2005 Premier Research appoints Anthony Orlando and Bruce C Stouch to New Senior Management Positions Premier Research Group plc (AIM: PRG) ("Premier Research", "Company" or "Group"), the international pharmaceutical services group today announces theappointment of -- Anthony Orlando, Ph.D and Bruce C Stouch Ph.D to seniormanagement positions in Premier Research. Dr Anthony Orlando, Ph.D has joined the US Operations of Premier Research Groupplc in the new position of Executive Director, Data Operations. Dr. Orlandobrings an exceptional background in Biostatistics and Data Management over thepast thirty years including key roles in pharmaceutical companies, the NationalCenter for Toxicological Research/FDA and at major contract researchorganizations. He most recently joined the company from his position as VicePresident, Biostatistics at SFBC New Drug Services. Dr. Orlando holds a Ph.D. inBiometry from Yale University, has co-authored many papers in his area ofexpertise and has supported several drug NDAs for a variety of indications. Hewill be responsible for US data management, programming and biostatistics forPremier Research. In addition to Dr. Orlando's position, Premier Research also is pleased toannounce that Bruce C. Stouch, Ph.D. has taken the international position ofChief Scientific Officer for the company. In Dr. Stouch's new role, he will leadthe company's efforts supporting expert FDA/statistical clinical design andanalysis capabilities. He will also establish and expand the company's newinitiative into Bayesian monitoring and analysis methods. Dr. Stouch has over15 years of biostatistics experience in pharmaceuticals. For 12 years, Dr. Stouch held position of Director of Biostatistics andScientific Data Management at Johnson & Johnson in Exton, PA, where he wasresponsible for strategic development and implementation of pharmacoeconomicmodels of emerging technologies in several therapeutic areas. Dr. Stouch hasbeen involved in over two dozen publications and acknowledgements. He holds anacademic appointment at the Philadelphia College of Medicine as Director,Biostatistics and Clinical Epidemiology. Dr. Stouch received his Ph.D. inBiostatistics and Epidemiology from Jefferson Medical College in 1997 through aprogram sponsored by Johnson & Johnson, and trained in post-graduate studiesfrom Temple University, Jefferson Medical College, and Harvard School of PublicHealth. Dr Simon Yaxley, CEO of Premier Research Group plc, commented: "We are proud andpleased to announce the significant strengthening of our data management andstatistics capabilities in the US Operations, we also believe that Tony andBruce place our company at the forefront of trial design, monitoring andanalysis methods worldwide." About Premier Research Premier Research Group plc is a contract research organisation focused on thedesign, management and reporting of all phases of clinical trials on behalf ofpharmaceutical and biotechnology companies. The Company specialises in oncology,central nervous system, paediatrics and anti-infectives. For Further information, please contact: Premier Research Group Plc Tel: 01344 458 311Dr Simon Yaxley, Chief Executive Buchanan Communications Tel: 020 7466 5000Lisa Baderoon/Diane Stewart/Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Sep 20073:41 pmRNSRule 8.3- Premier Research
25th Sep 200710:06 amRNSRule 8.3- Premier Research
20th Sep 200710:40 amRNSEPT Disclosure
19th Sep 20079:36 amRNSEPT Disclosure
18th Sep 200710:13 amRNSEPT Disclosure
12th Sep 200710:27 amRNSEPT Disclosure
11th Sep 200711:47 amRNSRule 8.3- Premier Research
10th Sep 20079:37 amRNSEPT Disclosure
7th Sep 200710:16 amRNSEPT Disclosure
6th Sep 200710:35 amRNSEPT Disclosure
5th Sep 200711:23 amRNSRule 8.3- Premier Research
4th Sep 20072:51 pmRNSRule 8.3-Premier Research Grp
4th Sep 200712:40 pmRNSAppointment of director
4th Sep 200711:30 amRNSHolding(s) in Company
4th Sep 200711:27 amRNSHolding(s) in Company
4th Sep 20079:36 amRNSEPT Disclosure
3rd Sep 20071:23 pmRNSRule 8.3- Premier Research
3rd Sep 20078:59 amRNSEPT Disclosure
31st Aug 200710:55 amRNSRule 8.3- Premier Research Gp
31st Aug 200710:21 amRNSEPT Disclosure
31st Aug 200710:19 amRNSRule 8.3- Premier Research
31st Aug 20079:45 amBUSRule 8.3 - Premier Research Group Plc
30th Aug 200712:28 pmRNSRule 8.3- Premier Research Gp
30th Aug 200710:57 amBUSRule 8.3 - Premier Research Group Plc
30th Aug 20079:14 amRNSEPT Disclosure
29th Aug 20077:02 amRNSRule 2.10 Announcement
29th Aug 20077:01 amRNSStatement re Possible Offer
20th Aug 20079:43 amRNSAIM Rule 26 information
10th Aug 20078:30 amRNSTrading Update
30th Jul 200711:50 amRNSHolding(s) in Company
24th Jul 200711:12 amRNSHolding(s) in Company
24th Jul 200711:11 amRNSHolding(s) in Company
24th Jul 200711:09 amRNSHolding(s) in Company
17th Jul 20077:00 amRNSAppointment of new Chairman
13th Jul 20077:00 amRNSAcquisition
12th Jul 20078:09 amRNSHolding(s) in Company
11th Jul 20073:31 pmRNSEGM Result
2nd Jul 20077:00 amRNSTrading Statement
2nd Jul 20077:00 amRNSTrading Statement
28th Jun 20075:59 pmRNSHolding in Company
27th Jun 20079:37 amRNSNotice of EGM
13th Jun 200710:42 amRNSAGM Statement
17th May 20072:51 pmRNSHolding(s) in Company
8th May 200712:13 pmRNSHolding(s) in Company
1st May 20077:01 amRNSHolding(s) in Company
26th Apr 200711:54 amRNSHolding(s) in Company
25th Apr 200710:44 amRNSPlacing of Stock
25th Apr 20077:00 amRNSWorkshop Morning
17th Apr 20077:02 amRNSPreliminary Results
19th Mar 20073:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.